October 24, 2025 | AG1 In September, AG1 announced a partnership with UC Davis and its Innovation Institute for Food & Health (IIFH)
Research suggests that AOD-9604 may activate beta-3 adrenergic receptors in fat cells, leading to enhanced fat oxidation
All products sold by Frontier Peptide Labs are laboratory research compounds intended exclusively for qualified research and development use
A 12-week facial cream study in 71 women documented increased skin density and thickness, reduced laxity, improved clarity, and reduced fine lines with wrinkle depth decreased significantly
Gene expression studies in RNA taken from bladder biopsies also suggest that disease mechanisms may differ in IC/BPS patients with and without Hunner lesions
Resistance training, adequate protein intake, sleep, and nutrition are not optional additions to GLP-1 therapy